Amplar Health and Australian Government Collaborate to Transform Aged Care with Virtual Nursing
Amplar Health and Australian Government Collaborate to Transform Aged Care with Virtual Nursing Amplar Health has announced a groundbreaking partnership with the Australian Government to introduce an innovative virtual nursing model aimed at supporting the aged care sector. This collaboration…
People-Powered, Tech-Enabled Pharmacy Experience
People-Powered, Tech-Enabled Pharmacy Experience A Tech-Enabled, People-Powered Pharmacy Experience Digital First, Not Digital Only In today’s rapidly evolving healthcare landscape, technology plays a crucial role in enhancing pharmacy care. Digital tools provide accessibility, personalization, and convenience, improving the overall experience…
Omeros Updates Zaltenibart Phase 3 PNH Trial
Omeros Updates Zaltenibart Phase 3 PNH Trial Omeros Corporation (Nasdaq: OMER) has announced significant progress in its Phase 3 clinical trial program for zaltenibart (OMS906), an investigational inhibitor of MASP-3, the key and most proximal activator of the alternative pathway…
VantAI Unveils Neo-1: AI Model for Molecular Interaction Design
VantAI Unveils Neo-1: AI Model for Molecular Interaction Design VantAI has unveiled Neo-1, the world’s most advanced atomistic foundation model, marking a significant milestone in molecular design and drug discovery. Announced at NVIDIA GTC 2025, Neo-1 is the first AI…
FDA Inspection Seminar: Preparation & Survival Guide (On-Demand)
FDA Inspection Seminar: Preparation & Survival Guide (On-Demand) ResearchAndMarkets.com has expanded its offerings with the addition of the “FDA Inspection Seminar: How to Prepare for and Survive an Inspection.” This on-demand training is designed to equip professionals across pharmaceutical, biopharmaceutical,…
Enigma Biomedical USA Selects 4R Tau PET Biomarker Candidate
Enigma Biomedical USA Selects 4R Tau PET Biomarker Candidate Enigma Biomedical USA, Inc. (EB USA) has announced the selection of two four-repeat tau (4R Tau) protein PET imaging biomarkers to advance into Phase 1 (Ph1) studies. This milestone follows EB…
Almirall’s 16th Skin Academy Unites Experts to Advance Dermatology
Almirall’s 16th Skin Academy Unites Experts to Advance Dermatology Almirall, a global pharmaceutical company specializing in medical dermatology, is hosting the 16th edition of its prestigious Skin Academy. This annual event serves as a premier conference for healthcare professionals in…
Revvity & Genomics England Expand Partnership for Newborn Genomic Research
Revvity & Genomics England Expand Partnership for Newborn Genomic Research Revvity, Inc. (NYSE: RVTY) has expanded its collaboration with Genomics England to further support the groundbreaking Generation Study, a national research initiative focused on newborn genomic sequencing. Under this enhanced…
ClostraBio Secures INVENT Illinois Investment, Names New CSO, Plans 2025 Product Launch
ClostraBio Secures INVENT Illinois Investment, Names New CSO, Plans 2025 Product Launch ClostraBio, Inc., a pioneering biotechnology company dedicated to harnessing natural pathways for gut health management, has announced new institutional investors participating in its latest bridge financing round. Among…
BIOQuébec Expands to Include Medtech and Boosts Industry Representation
BIOQuébec Expands to Include Medtech and Boosts Industry Representation BIOQuébec is making a strategic and forward-looking move by broadening its reach to encompass the entire life sciences and health technologies (LSHT) sector. This expansion marks a significant milestone, solidifying the…
Caron Treatment Centers Expands Addiction Programs for Adults in Florida
Caron Treatment Centers Expands Addiction Programs for Adults in Florida Caron Treatment Centers, a nationally recognized nonprofit dedicated to addiction and behavioral healthcare treatment, research, prevention, and education, has announced a significant expansion of its services in Florida. Beginning in…
Wheeler Bio Raises $35M in Oversubscribed Series, Plans Expansion
Wheeler Bio Raises $35M in Oversubscribed Series, Plans Expansion Wheeler Bio, a pioneering contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of antibody-based therapies, has successfully closed an oversubscribed Series A-1 financing round, raising $35…